Literature DB >> 3884196

Bovine serum albumin (BSA) nephritis in rats. III. Antigen distribution in various organs.

S Miyazaki, K Kawasaki, E Yaoita, T Yamamoto, I Kihara.   

Abstract

We established an experimental model of immune complex glomerulonephritis (ICGN) in rats by daily i.v. administration of 2.0 mg of bovine serum albumin (BSA) for 4 weeks (Yamamoto et al., 1978). In the present study, antigen distribution among various organs was evaluated in the whole course of the experimental rat model using the paired radiolabel technique and the direct immunofluorescent method. In the late stage of chronic serum sickness (CSS), antigen distribution to the liver decreased and that to the glomeruli increased remarkedly whereas hepatic distribution of the antigen was the highest among the organs in the early stage of CSS. BSA distribution in the glomeruli correlated positively with the distribution in blood and there was an inverse relationship between glomerular distribution of BSA and hepatic distribution throughout the course of CSS. These observations may show direct evidence that events in the liver influence the development of ICGN.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884196      PMCID: PMC1577151     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Experimental chronic serum sickness in rats. A model of immune complex glomerulonephritis and systemic immune complex deposition.

Authors:  L Arisz; B Noble; M Milgrom; J R Brentjens; G A Andres
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

4.  In vivo uptake of immune complexes by parenchymal and nonparenchymal liver cells in mice.

Authors:  U Hopf; H E Schaefer; G Hess; K H Meyer Zum Büschenfelde
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

5.  Studies on the micro-quantitation of antibody by the reversed type single radial immunodiffusion.

Authors:  H Nariuchi; M Usui; T Matuhasi
Journal:  Jpn J Exp Med       Date:  1970-02

6.  Experimental glomerulonephritis in rats.

Authors:  R H Fennell; V M Pardo
Journal:  Lab Invest       Date:  1967-11       Impact factor: 5.662

7.  Bovine serum albumin chronic serum sickness nephropathy in rats.

Authors:  W K Bolton; B C Sturgill
Journal:  Br J Exp Pathol       Date:  1978-04

8.  Hepatic uptake of small-latticed immune complexes does not alter mononuclear phagocyte system function.

Authors:  R A Jimenez; A O Haakenstad; M Mannik
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

9.  Bovine serum albumin (BSA) nephritis in rats. I. Experimental model.

Authors:  T Yamamoto; I Kihara; T Morita; T Oite
Journal:  Acta Pathol Jpn       Date:  1978-11

10.  The effect of in situ formation of antigen-antibody complexes in the glomerulus on subsequent glomerular localization of passively administered immune complexes.

Authors:  P M Ford; I Kosatka
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

View more
  3 in total

1.  Bovine serum albumin nephritis in rats. V. Kinetic studies of antigen localization in various organs and the phagocytic role of polymorphonuclear leukocytes.

Authors:  S Miyazaki; K Kawasaki; E Yaoita; T Yamamoto; I Kihara
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

2.  An assessment of the influence of antigen dose in two new models of chronic serum sickness glomerulonephritis in the rat.

Authors:  P N Furness; D R Turner
Journal:  Br J Exp Pathol       Date:  1987-08

3.  Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.

Authors:  H Vlassara; L J Striker; S Teichberg; H Fuh; Y M Li; M Steffes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.